Opioid Analgesics for NCLEX: Morphine, Fentanyl, Naloxone & Safe Administration
NCLEX opioid analgesic review covering morphine, fentanyl, hydromorphone, and naloxone. Learn safe administration, monitoring, and overdose management.
Opioid Analgesics for NCLEX Review
Opioid analgesics are a critical pharmacology topic on the NCLEX, covering medication administration safety, monitoring for respiratory depression, patient education, and overdose management. Understanding opioid pharmacology ensures safe pain management practice.
Common Opioid Medications
Morphine is the prototype opioid analgesic and the standard against which others are compared. It is used for moderate to severe pain, acute MI, and pulmonary edema. Side effects include respiratory depression, constipation, urinary retention, nausea, and histamine release causing hypotension and pruritus. Fentanyl is 80-100 times more potent than morphine and available in IV, transdermal patch, and lozenge forms. The transdermal patch takes 12-24 hours to reach therapeutic levels and should not be used for acute pain. Hydromorphone (Dilaudid) is 5-7 times more potent than morphine and is used when morphine is contraindicated or ineffective. Oxycodone and hydrocodone are commonly prescribed oral opioids for moderate to severe pain.
Safe Administration and Monitoring
Before administering any opioid, assess pain level, respiratory rate (hold if below 12 breaths per minute), level of sedation, and blood pressure. Monitor oxygen saturation continuously for patients receiving IV opioids, especially opioid-naive patients. Assess for oversedation using a sedation scale as excessive sedation often precedes respiratory depression. Keep naloxone (Narcan) readily available. Start with the lowest effective dose and titrate based on response. Use multimodal analgesia (combining opioids with non-opioid medications like acetaminophen or NSAIDs) to reduce opioid requirements.
Naloxone (Narcan)
Naloxone is an opioid antagonist that reverses opioid effects including respiratory depression. Onset of action is 1-2 minutes IV. Duration is 30-90 minutes, which may be shorter than the opioid being reversed, requiring repeat dosing and continuous monitoring. Administer in small increments to avoid precipitating severe pain, acute withdrawal, and hemodynamic instability. Monitor closely for renarcotization after naloxone wears off.
Patient Education
Teach patients about common side effects, especially constipation (initiate a bowel regimen prophylactically). Avoid alcohol and CNS depressants. Do not drive or operate machinery until effects are known. Store securely and dispose of unused opioids properly. Review with our pharmacology flashcards and practice pharmacology mini-exams.